Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 22.05% | -135.46% | -264.27% | 36.88% | 116.65% |
| Total Depreciation and Amortization | 64.55% | -15.77% | -9.91% | 12.09% | 11.85% |
| Total Amortization of Deferred Charges | -87.82% | -11.56% | -42.88% | -79.08% | 543.16% |
| Total Other Non-Cash Items | 18.72% | -70.35% | -57.96% | -20.32% | -56.55% |
| Change in Net Operating Assets | -20.55% | 158.15% | 177.27% | 50.32% | -884.95% |
| Cash from Operations | -31.10% | -85.14% | -52.39% | -48.95% | 484.33% |
| Capital Expenditure | -2,494.44% | 103.64% | 59.57% | 62.18% | -148.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,494.44% | 103.64% | 59.57% | 62.18% | -148.54% |
| Total Debt Issued | -- | -- | -- | 100.00% | -108.42% |
| Total Debt Repaid | -1,044.71% | 83.02% | 74.12% | 69.64% | -949.14% |
| Issuance of Common Stock | -- | -- | -- | -86.54% | 7,108.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 202.79% | 83.02% | 60.22% | 13.38% | -317.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,270.87% | 77.80% | 87.11% | -189.09% | 1,833.97% |